Discover how drug-surviving leukemia cells exhibit cancer stem cell-like properties, driving treatment resistance and metastasis in leukemia patients.
Exploring the development of benzimidazole-1,2,3-triazole hybrid molecules as multi-target cancer therapies that overcome drug resistance.